Source: Eur Respir Monogr 2020; 88: 66-81
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Josuel Ora, Francesco Cavalli, Mario Cazzola. Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits. Eur Respir Monogr 2020; 88: 66-81

Member's Comments

No comment yet.

Related content which might interest you: Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Do cardiovascular drugs reduce mortality in patients with COPD in daily practice? A study in primary care Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care Year: 2007 Natural history of disease burden for US patients with asthma vs asthma and COPD Source: Virtual Congress 2020 – Risk factors for chronic lung diseases Year: 2020 Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk? Source: Eur Respir J 2015; 46: 846-849 Year: 2015 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Assessment of a disease management program for patients with asthma or COPD Source: Eur Respir J 2005; 26: Suppl. 49, 19s Year: 2005 Exacerbations and mortality of COPD patients with cardiovascular disease in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 LATE-BREAKING ABSTRACT: No relationship between cardiovascular morbidity and moderate-to-severe exacerbation rates in COPD patients in primary care Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Cardiovascular risk assessment in COPD patients with severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Coexistence of cardiovascular diseases in patients with COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Role of comorbidities in stable COPD patients mortality Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Are current treatment recommendations suited to elderly patients with asthma or COPD? Source: Eur Respir Mon; 2009: 43: 267–285 Year: 2009 Chronic asthma and the risk of cardiovascular disease Source: Eur Respir Monogr 2020; 88: 82-95 Year: 2020 Prevalence of cardiovascular disease in COPD patients in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 The risk of hyperkalemia in COPD and asthma patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013